T 0229/97 (Atorvastatin/WARNER-LAMBERT) of 20.07.2000
- European Case Law Identifier
- ECLI:EP:BA:2000:T022997.20000720
- Date of decision
- 20 July 2000
- Case number
- T 0229/97
- Online on
- 31 October 2000
- Petition for review of
- -
- Application number
- 90113986.5
- IPC class
- C07D 207/327
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- (R-(R*R*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(-1-methylethyl-3-phenyl-4((phenylamino) -carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
- Applicant name
- WARNER-LAMBERT COMPANY
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 56 1973
- Keywords
- Inventive step (yes, after amendment) - proper comparison - unexpectedly improved handling
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to grant a patent on the basis of the description pages 1 to 20 and the claims 1 to 4, both as submitted during the oral proceedings on 20 July 2000.